Drug Profile
CD4 IgG
Alternative Names: CD4 Antigens; CD4 Immunoadhesin; Hybrid CD4; Recombinant CD4 Immunoglobulin G; Recombinant human CD4 Immunoglobulin G; Recombinant soluble CD4 Immunoglobulin G; rsCD4 IgGLatest Information Update: 12 Apr 2018
Price :
$50
*
At a glance
- Originator Genentech
- Class Anti-inflammatories; Antipsoriatics; Antirheumatics; Antivirals; Immunoglobulin Fc fragments; Immunoglobulin fusion proteins; Recombinant fusion proteins
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections; Idiopathic thrombocytopenic purpura
Most Recent Events
- 28 Oct 2005 Discontinued - Phase-I for HIV-associated Idiopathic thrombocytopenic purpura in USA (IV)
- 28 Oct 2005 Discontinued-I for HIV infections in USA (IV)
- 02 Nov 1999 Phase-I clinical trials in HIV-associated Idiopathic thrombocytopenic purpura in USA (IV)